Last news
Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

...

Bitget Wallet Lite Hits 6 Million Users in Days, Now The Largest Telegram Wallet

Bitget Wallet Lite Hits 6 Million Users in Days, Now The Largest Telegram Wallet

...

Colliers named one of Forbes’ World’s Best Employers 2024

Colliers named one of Forbes’ World’s Best Employers 2024

...

Monetary Authority of Singapore Nominates Hakeem App for 2024 Singapore Fintech Excellence Awards

Monetary Authority of Singapore Nominates Hakeem App for 2024 Singapore Fintech Excellence Awards

...

Bombardier’s New Brand Evolution Wins Two Red Dot Awards for Brand Design Excellence

Bombardier’s New Brand Evolution Wins Two Red Dot Awards for Brand Design Excellence

...

18th Global Citizenship Conference to be held in Singapore

18th Global Citizenship Conference to be held in Singapore

...

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

...

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as

...

1 ... 377 378 379 380 381 382 383 384 385 ... 1035
menu
menu